Answers are grounded in this paper and cite their sources.
Plant-derived bioactive compounds are increasingly used in functional foods and nutraceuticals for their potential health benefits, but their application is limited by poor solubility, chemical instability, and degradation during processing and gastrointestinal digestion. Alginate, a naturally derived anionic polysaccharide with ionotropic gel-forming properties, provides a versatile food-grade platform for their encapsulation and controlled delivery. This review critically examines the relationship between alginate matrix design, gastrointestinal fate, bioaccessibility, and biological relevance of encapsulated plant-based bioactives. Particular attention is given to the effects of alginate composition, calcium-mediated crosslinking, matrix architecture, complementary materials, and encapsulation conditions on bioactive retention, gastrointestinal release, and intestinal bioaccessibility. The reviewed evidence demonstrates that high encapsulation efficiency does not necessarily translate into enhanced bioaccessibility, while increased bioaccessibility cannot be equated with systemic bioavailability or health benefit. Cell-based evidence is further considered to distinguish formulation-dependent biological activity from direct evidence of cellular uptake and intracellular exposure. Overall, alginate should be viewed not simply as a protective carrier, but as a structural platform capable of modulating the gastrointestinal and cellular availability of plant-derived bioactives. This perspective links formulation performance with biological relevance and provides a framework for assessing the potential of alginate-based systems in health-oriented food applications.
No takes yet. Share an insight, caveat, or question.
Pokorski et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: